Literature DB >> 8643547

Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.

J D Erickson1, M K Schafer, T I Bonner, L E Eiden, E Weihe.   

Abstract

A second isoform of the human vesicular monoamine transporter (hVMAT) has been cloned from a pheochromocytoma cDNA library. The contribution of the two transporter isoforms to monoamine storage in human neuroendocrine tissues was examined with isoform-specific polyclonal antibodies against hVMAT1 and hVMAT2. Central, peripheral, and enteric neurons express only VMAT2. VMAT1 is expressed exclusively in neuroendocrine, including chromaffin and enterochromaffin, cells. VMAT1 and VMAT2 are coexpressed in all chromaffin cells of the adrenal medulla. VMAT2 alone is expressed in histamine-storing enterochromaffin-like cells of the oxyntic mucosa of the stomach. The transport characteristics and pharmacology of each VMAT isoform have been directly compared after expression in digitonin-permeabilized fibroblastic (CV-1) cells, providing information about substrate feature recognition by each transporter and the role of vesicular monoamine storage in the mechanism of action of psychopharmacologic and neurotoxic agents in human. Serotonin has a similar affinity for both transporters. Catecholamines exhibit a 3-fold higher affinity, and histamine exhibits a 30-fold higher affinity, for VMAT2. Reserpine and ketanserin are slightly more potent inhibitors of VMAT2-mediated transport than of VMAT1-mediated transport, whereas tetrabenazine binds to and inhibits only VMAT2. N-methyl-4-phenylpyridinium, phenylethylamine, amphetamine, and methylenedioxymethamphetamine are all more potent inhibitors of VMAT2 than of VMAT1, whereas fenfluramine is a more potent inhibitor of VMAT1-mediated monamine transport than of VMAT2-mediated monoamine transport. The unique distributions of hVMAT1 and hVMAT2 provide new markers for multiple neuroendocrine lineages, and examination of their transport properties provides mechanistic insights into the pharmacology and physiology of amine storage in cardiovascular, endocrine, and central nervous system function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643547      PMCID: PMC39426          DOI: 10.1073/pnas.93.10.5166

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2.

Authors:  B Seed
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

3.  Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.

Authors:  J F Reinhard; E J Diliberto; O H Viveros; A J Daniels
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat.

Authors:  D Poynter; C R Pick; R A Harcourt; S A Selway; G Ainge; I W Harman; N W Spurling; P A Fluck; J L Cook
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

5.  Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion.

Authors:  N Havu
Journal:  Digestion       Date:  1986       Impact factor: 3.216

6.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

Authors:  J W Langston; P Ballard; J W Tetrud; I Irwin
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

7.  Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain.

Authors:  G A Ricaurte; R W Guillery; L S Seiden; C R Schuster; R Y Moore
Journal:  Brain Res       Date:  1982-03-04       Impact factor: 3.252

8.  Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.

Authors:  R R Ramsay; T P Singer
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

9.  Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

Authors:  G Ricaurte; G Bryan; L Strauss; L Seiden; C Schuster
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

10.  Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies.

Authors:  R Håkanson; G Böttcher; E Ekblad; P Panula; M Simonsson; M Dohlsten; T Hallberg; F Sundler
Journal:  Histochemistry       Date:  1986
View more
  117 in total

1.  Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

Authors:  W Y Lee; J W Chang; N L Nemeth; U J Kang
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

Review 2.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 3.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

Review 4.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

5.  Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

Authors:  Lucia Martiniova; Susannah Cleary; Edwin W Lai; Dale O Kiesewetter; Jurgen Seidel; Linda F Dawson; Jacqueline K Phillips; David Thomasson; Xiaoyuan Chen; Graeme Eisenhofer; James F Powers; Richard Kvetnansky; Karel Pacak
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

6.  The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2).

Authors:  M Höltje; B von Jagow; I Pahner; M Lautenschlager; H Hörtnagl; B Nürnberg; R Jahn; G Ahnert-Hilger
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

7.  Expression of metanephric nephron-patterning genes in differentiating mesonephric tubules.

Authors:  K M Georgas; H S Chiu; E Lesieur; B A Rumballe; Melissa H Little
Journal:  Dev Dyn       Date:  2011-04-12       Impact factor: 3.780

8.  Deletion of Go2alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system.

Authors:  Irene Brunk; Christian Blex; Carles Sanchis-Segura; Jan Sternberg; Stephanie Perreau-Lenz; Ainhoa Bilbao; Heide Hörtnagl; Jens Baron; Judyta Juranek; Gregor Laube; Lutz Birnbaumer; Rainer Spanagel; Gudrun Ahnert-Hilger
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

9.  Genetic association analysis of 300 genes identifies a risk haplotype in SLC18A2 for post-traumatic stress disorder in two independent samples.

Authors:  Nadia Solovieff; Andrea L Roberts; Andrew Ratanatharathorn; Michelle Haloosim; Immaculata De Vivo; Anthony P King; Israel Liberzon; Allison Aiello; Monica Uddin; Derek E Wildman; Sandro Galea; Jordan W Smoller; Shaun M Purcell; Karestan C Koenen
Journal:  Neuropsychopharmacology       Date:  2014-02-14       Impact factor: 7.853

10.  A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles.

Authors:  Etienne A Cartier; Leonardo A Parra; Tracy B Baust; Marisol Quiroz; Gloria Salazar; Victor Faundez; Loreto Egaña; Gonzalo E Torres
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.